{"id":401,"date":"2025-10-30T10:00:00","date_gmt":"2025-10-30T01:00:00","guid":{"rendered":"https:\/\/engitissuedesign.com\/?p=401"},"modified":"2026-09-28T15:33:53","modified_gmt":"2026-09-28T06:33:53","slug":"nyemission-genomford-aktiekapitalet-hojt-till-cirka-60-miljoner-yen","status":"publish","type":"post","link":"https:\/\/engitissuedesign.com\/sv\/nyemission-genomford-aktiekapitalet-hojt-till-cirka-60-miljoner-yen\/","title":{"rendered":"Nyemission genomf\u00f6rd \u2013 aktiekapitalet h\u00f6jt till cirka 60 miljoner yen"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Vi meddelar att EngiTissue Design Co., Ltd. den 30 oktober 2025 genomf\u00f6rde en nyemission genom utgivning av nya aktier och h\u00f6jde aktiekapitalet till 61\u202f351\u202f300 yen.<\/p>\n<p class=\"wp-block-paragraph\">D\u00e4rmed h\u00f6jdes bolagets kapital fr\u00e5n de 10\u202f000\u202f000 yen som registrerades vid bildandet. Detaljerna \u00e4r f\u00f6ljande:<\/p>\n<ul class=\"wp-block-list\"><li>Ikrafttr\u00e4dandedatum: 30 oktober 2025<\/li><li>Aktiekapital efter emissionen: 61\u202f351\u202f300 yen<\/li><li>Totalt antal utgivna aktier efter emissionen: 1\u202f114 aktier<\/li><\/ul>\n<p class=\"wp-block-paragraph\">Medlen som tagits in genom denna nyemission kommer att anv\u00e4ndas f\u00f6r att fr\u00e4mja forskning och utveckling av v\u00e5ra iPSC-baserade organoid- och 3D-v\u00e4vnadsplattformar och f\u00f6r att st\u00e4rka v\u00e5r aff\u00e4rsstruktur. Vi tackar f\u00f6r ert fortsatta st\u00f6d.<\/p>","protected":false},"excerpt":{"rendered":"<p>Vi meddelar att EngiTissue Design Co., Ltd. den 30 oktober 2025 genomf\u00f6rde en nyemission genom utgivning av nya aktier och h\u00f6jde aktiekapitalet till 61\u202f351\u202f300 yen. D\u00e4rmed h\u00f6jdes bolagets kapital fr\u00e5n de 10\u202f000\u202f000 yen som registrerades vid bildandet. Detaljerna \u00e4r f\u00f6ljande: Ikrafttr\u00e4dandedatum: 30 oktober 2025 Aktiekapital efter emissionen: 61\u202f351\u202f300 yen Totalt antal utgivna aktier efter emissionen: [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":597,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[103],"tags":[],"class_list":["post-401","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ir-och-kapital"],"_links":{"self":[{"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/posts\/401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/comments?post=401"}],"version-history":[{"count":1,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/posts\/401\/revisions"}],"predecessor-version":[{"id":402,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/posts\/401\/revisions\/402"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/media\/597"}],"wp:attachment":[{"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/media?parent=401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/categories?post=401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/engitissuedesign.com\/sv\/wp-json\/wp\/v2\/tags?post=401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}